Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets by Tusche, Michael W. et al.
Article
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 206 No. 12  2671-2683
www.jem.org/cgi/doi/10.1084/jem.20091802
2671
        The NF-    B family of heterodimeric transcrip-
tion factors plays a critical role in cellular func-
tions such as immunoregulation, infl  ammation, 
cell survival, and cell-cycle progression (  Li and 
Verma, 2002  ;   Hayden and Ghosh, 2004  ). NF-    B 
subunits include RelA (p65), RelB, c-Rel, NF-
    B1 (p50), and NF-    B2 (p52). NF-    B1 and 
NF-    B2 are synthesized as large precursors (p105 
and p100, respectively) that are processed to the 
transcriptionally active p50 and p52 subunits in 
response to cytokine signaling. 
  NF-    B heterodimers are activated by either 
a canonical or a noncanonical pathway (  Hayden 
and Ghosh, 2004  ). The canonical pathway de-
pends on activation of I    B kinase (IKK)     , which 
phosphorylates inhibitory I    B molecules bound 
to NF-    B subunits such as RelA, allowing 
NF-    B to translocate to the nucleus (  Hayden 
and Ghosh, 2004  ). The noncanonical pathway 
depends on activation of IKK     (  Senftleben et al., 
2001  ). NF-    B–inducing kinase (NIK) phos-
phorylates and activates IKK     in response to 
various stimuli (  Ling et al., 1998  ). NIK has also 
been shown to phosphorylate p100 at serines 
866 and 870 (  Xiao et al., 2001  ). Activated IKK     
then drives the serine phosphorylation of I    B-
like domains within the NF-    B subunits them-
selves, such as those present in NF-    B2 p100 
(  Senftleben et al., 2001  ). Polyubiquitination and 
degradation of these phosphorylated domains 
allows p52 to enter the nucleus. 
  A known activator of noncanonical NF-    B 
signaling is B cell activation factor of the TNF 
family (BAFF; also known as BLyS, TALL-1, 
THANK, zTNF-1, and TNFSF13B;   Schneider 
et al., 1999  ). In particular, BAFF induces the 
processing of p100 to p52 (  Claudio et al., 2002  ; 
  Kayagaki et al., 2002 ). BAFF is expressed by neu-
trophils, monocytes, and dendritic cells ( Nardelli 
et al., 2001  ), and promotes B cell survival by 
up-regulating the antiapoptotic molecules Bcl-2 
and Bcl-xL (  Mackay et al., 1999  ;   Batten et al., 
2000  ;   Schiemann et al., 2001  ). BAFF can also 
induce cell-cycle entry by triggering cyclin D2 
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  B cell activation factor of the TNF family (BAFF) activates noncanonical nuclear factor     B 
(NF-    B) heterodimers that promote B cell survival. We show that although MALT1 is 
largely dispensable for canonical NF-    B signaling downstream of the B cell receptor, the 
absence of MALT1 results in impaired BAFF-induced phosphorylation of NF-    B2 (p100), 
p100 degradation, and RelB nuclear translocation in B220  +   B cells. This corresponds with 
impaired survival of MALT1      /      marginal zone (MZ) but not follicular B cells in response to 
BAFF stimulation in vitro. MALT1      /      MZ B cells also express higher amounts of TRAF3, a 
known negative regulator of BAFF receptor–mediated signaling, and TRAF3 was found to 
interact with MALT1. Furthermore, phenotypes associated with overexpression of BAFF, 
including increased MZ B cell numbers, elevated serum immunoglobulin titers, and sponta-
neous germinal center formation, were found to be dependent on B cell–intrinsic MALT1 
expression. Our results demonstrate a novel role for MALT1 in biological outcomes induced 
by BAFF-mediated signal transduction. 
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subtle role in B cell survival after BCR engagement, and its 
role in the survival of FO versus MZ B cells has not been de-
termined (  Ruefl  i-Brasse et al., 2003  ;   Ruland et al., 2003  ). We 
fi  rst examined whether MALT1 is required for B cell prolif-
eration triggered by BCR engagement by stimulating purifi  ed, 
resting B220  +   B cells from WT, MALT1      /     , and Bcl10      /      
mice with anti-IgM and monitoring [  3  H]thymidine incorpo-
ration. As expected, the proliferation of Bcl10      /      B cells was 
signifi  cantly reduced, but no statistically signifi  cant diff  erence 
in proliferation was noted between WT and MALT1      /      
B cells (  Fig. 1 A,   i).   MALT1  +/+   and MALT1      /      B cells were 
also treated with increasing doses of anti-IgM, and prolifera-
tion was assessed at 24 h (  Fig. 1 A  , ii). No signifi  cant diff  erences 
were noted between genotypes. Consistent with this result, 
anti-IgM treatment stimulated I    B     degradation in WT and 
MALT1      /      B cells but not in Bcl10      /      B cells (  Fig. 1 B  ). 
Furthermore, anti-IgM induced the up-regulation of p65-de-
pendent DNA binding in WT and MALT1      /      B cells but 
not in Bcl10      /      B cells (  Fig. 1 C  ). The CD40 pathway is also 
important in B cell activation and proliferation. We therefore 
also examined the role of MALT1 in anti-CD40–mediated B 
cell proliferation. We found no diff  erences in B cell proliferation 
in response to anti-CD40 treatment of WT versus MALT1      /      
B cells (  Fig. 1 A  , iii). Furthermore, CD40L stimulation also 
induced I    B     degradation and p100 processing in WT and 
MALT1      /      B cells (  Fig. S1, A and B  ). Therefore, our data 
imply that CD40-mediated signaling pathways are intact in 
MALT1      /      B cells. 
  A subtle role for MALT1 in B cell survival has been previ-
ously demonstrated (  Ferch et al., 2007  ), but B cell survival 
and activation of MALT1      /      MZ versus FO B cells has not 
been examined. We therefore sorted, FO and the small num-
ber of MZ B cells from MALT1      /      and WT mice (  Fig. S2  ) 
and evaluated diff  erent parameters after BCR stimulation. In 
agreement with another report ( Ferch et al., 2007 ), MALT1      /      
FO B cells were slightly more susceptible to IgM-induced cell 
death. However MALT1      /      MZ B cells responded much 
like MALT1  +/+   MZ B cells (  Fig. 1 D  ). Because MZ B cells 
are prone to die in culture in response to anti-BCR stimula-
tion, we examined the up-regulation of B7-2 on MZ B cells 
that is linked to BCR simulation (  Oliver et al., 1997  ). We 
found that B7.2 was equally up-regulated in MALT1  +/+   and 
MALT1      /      MZ B cells, and FO B cells treated with anti-IgM 
stimulation (  Fig. 1 E  ). In addition, sorted T2 cells from 
MALT1  +/+   and MALT1      /      mice were found to have similar 
survival responses (  Fig. S3 A  ) and B7.2 up-regulation profi  les 
in response to anti-BCR stimulation (Fig. S3 B). Collectively, 
MALT1 is not essential for IgM-induced I    B     degradation or 
p65 DNA binding nor is it absolutely required for the survival 
of FO, MZ, and T2 B cells, or for anti-BCR–induced B7-2 
up-regulation in these B cells subsets. 
  BAFF-induced p100 phosphorylation and degradation are 
diminished in MALT1      /      B cells 
  Given that MALT1      /      mice exhibit a reduction in MZ and 
B1 B cells and that BCR signaling in MALT1      /      B cells is 
synthesis (  Huang et al., 2004  ). BAFF-induced transitional B 
cell survival is required for the development of mature B cell 
subsets, including CD21  low  CD23  high   follicular (FO) B cells as 
well as CD21  high  CD23  low   marginal zone (MZ) B cells (  Batten 
et al., 2000  ). Mice that overexpress BAFF (BAFF-Tg) exhibit 
an expanded MZ B cell compartment, hyper-Ig production, 
and spontaneous germinal center (GC) formation concomitant 
with autoimmune symptoms (  Mackay et al., 1999  ;   Khare 
et al., 2000  ). 
  BAFF binds to three diff  erent receptors: B cell maturation 
antigen (BCMA;   Marsters et al., 2000  ;   Thompson et al., 2000  ), 
transmembrane activator and calcium modulator and cyclophilin 
ligand interactor (TACI;   Marsters et al., 2000  ;   Thompson 
et al., 2000  ;   Wu et al., 2000  ), and BAFF-R (  Thompson et al., 
2001  ;   Yan et al., 2001  ). Knockout studies have shown that 
the functions of these receptors are distinct, with only BAFF-R 
being necessary for B cell survival and maturation (  Sasaki et al., 
2004  ). Signals downstream of the BAFF-R are known to ac-
tivate noncanonical NF-   B heterodimers ( Claudio et al., 2002  ; 
  Kayagaki et al., 2002  ), and BAFF      /      mice exhibit a complete 
block in FO and MZ B cell development (  Schiemann et al., 
2001  ). However, mice with defi  ciencies or harboring muta-
tions for various elements of the NF-    B2 pathway used by 
BAFF-R signaling, such as RelB and NIK (  Shinkura et al., 
1999  ;   Weih et al., 2001  ), do not completely phenocopy 
BAFF      /      mice in terms of B cell development. This suggests 
that various parallel pathways emanate from the BAFF-R 
that leads to the development of diff  erent B cell subsets. 
  MALT1 and Bcl10 are signal integrators that are crucial 
for canonical NF-    B activation downstream of the TCR 
(  Ruland et al., 2001, 2003  ;   Ruefl  i-Brasse et al., 2003  ;   Xue 
et al., 2003  ). However, the role of MALT1 downstream of 
the BCR is more subtle and not essential for the manifesta-
tion of many BCR-derived signals (  Ruefl   i-Brasse et al., 
2003  ;   Ruland et al., 2003  ). Because MALT1      /      mice exhibit 
a reduction in MZ and B1 B cells, this raises the question that 
perhaps MALT1 may be involved in BAFF-R–mediated 
signaling to maintain some but not all B cell subsets. In this 
study, we show that MALT1 is necessary for BAFF-induced 
survival of MZ B cells but not FO B cells, and is involved in 
the optimal activation of NF-    B2 in B cells stimulated with 
BAFF. In addition, the phenotype of BAFF-Tg mice is de-
pendent on MALT1 in spite of the fact that MALT1 is not 
essential for BCR signaling in vitro. 
  RESULTS 
  MALT1 is not essential for B cell proliferation, B cell 
survival, I    B     degradation, and NF-    B activation induced 
by BCR engagement 
  Several groups have shown that MALT1 is necessary for MZ 
and B1 B cell development, whereas Bcl10 leads to a more 
profound developmental defect aff  ecting FO, MZ, and B1 B 
cells (  Ruefl  i-Brasse et al., 2003  ;   Ruland et al., 2003  ;   Xue et al., 
2003  ). Though Bcl10 has been shown to impinge on the ac-
tivation of NF-    B downstream of both TCR and BCR and 
is essential for B cell survival, MALT1 appears to play a more JEM VOL. 206, November 23, 2009 
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p100 was degraded to yield the transcriptionally active p52 
subunit (  Fig. 2 A  , cytoplasmic), concomitant with an increase 
in nuclear p52 (  Fig. 2 A  , nuclear). In contrast, MALT1      /      B 
cells generated reduced levels of p52 in response to BAFF 
(  Fig. 2 A  , cytoplasmic). BAFF stimulation also led to the 
nuclear accumulation of RelB in WT B cells, which was re-
duced in MALT1      /      B cells (  Fig. 2 A  , nuclear). Therefore, 
BAFF-dependent activation of NF-    B2 is impaired in 
MALT1      /      B cells. 
  Certain B cell populations are known to be underrepre-
sented in MALT1      /      mice, particularly CD21  high  CD23  low   
largely intact, we hypothesized that MALT1 may be impor-
tant for BAFF-dependent B cell survival signals for the main-
tenance of some B cell subsets. To evaluate the role of 
MALT1 in noncanonical NF-    B signaling, we stimulated 
purifi  ed WT and MALT1      /      resting B cells with recombi-
nant BAFF and examined NF-    B2 (p100) degradation. We 
fi  rst confi  rmed that MALT1      /      splenic B cells expressed WT 
levels of BAFF-R (  Fig. S4  ), as well as normal levels of signal-
ing intermediates downstream of BAFF-R such as RelB, 
p100, and TRAF2 (  Fig. 2 A   and not depicted).   Immunoblot-
ting showed that in BAFF-stimulated WT B220  +   B cells, 
    Figure 1.     MALT1 is dispensable for B cell proliferation and canonical NF-    B activation induced by BCR engagement.   (A)  B220 +   B cells were 
isolated from spleens of WT (white bars), Bcl10     /     (black bars), and MALT1     /     (gray bars) mice and stimulated for 24 or 48 h with 5 μg/ml anti-IgM (i), or 
for 24 h with the indicated doses of anti-IgM (ii) or anti-CD40 (iii). Proliferation was assessed by [  3  H]thymidine incorporation. Results shown are means ± 
SD of three replicates per genotype and are representative of three independent analyses. (B) Purifi  ed splenic B cells from WT, Bcl10     /    , and MALT1     /    
mice were stimulated with 5 μg/ml anti-IgM for the indicated times, and lysates were Western blotted to detect I   B   . Results shown are representative 
of three independent analyses. (C) Nuclear lysates were prepared from unstimulated B cells or from B cells that had been treated for 8 h with anti-IgM 
from the indicated genotypes. Lysates were subjected to EMSA to detect up-regulation of binding to NF-    B DNA consensus sequences (p65). Results 
shown are representative of at least three independent analyses. (D) MZ and FO B cells were sorted from the indicated genotypes. Cells were treated with 
5 μg/ml anti-IgM for the indicated times, and viability was assessed using annexin V/PI staining as described. Experiments shown are representative of 
three independent analyses. (E) Splenocytes from the indicated genotypes were cultured for 12 h with 5 μg/ml anti-IgM, and B7 up-regulation was as-
sessed in the MZ and FO compartments as described in Materials and methods. Anti-IgM–treated samples (blue) were treated with 5 μg/ml for 12 h. 
Numbers to the left of gels represent kilodaltons.     2674 The role of MALT1 in BAFF-mediated effects   | Tusche et al. 
  To further elucidate the role of MALT1 in BAFF signal 
transduction, we ablated MALT1 expression using RNAi-
mediated silencing. Using BJAB cells that express BAFF-R 
but not BCMA or TACI (  Thompson et al., 2001  ), we ob-
served a nearly complete silencing of MALT1 expression (  Fig. 
2 C  , cytoplasmic). Nuclear translocation of RelB induced by 
BAFF was found to be impaired in BJAB MALT1 knock-
down cells compared with cells nucleofected with scrambled 
siRNA control (  Fig. 2 C  , nuclear). BJAB cells appear to have 
a high level of basal p100 processing (unpublished data), mak-
ing it diffi   cult to observe diff  erences in p100 degradation in 
the absence of MALT1 in this particular cell line. Nevertheless, 
increases in phospho-p100 induced by BAFF pretreatment 
were absent in MALT1 knockdown BJAB cells compared 
with controls (  Fig. 2 D  ). To validate the p100 phosphoryla-
tion readout, we also performed a knockdown of p100 in 
BJAB cells (  Fig. 2 D  , right) and found that staining for phospho-
p100 was completely abolished in BJAB cells (  Fig. 2 D  , 
left). In addition, a p100 phospho-shift was not observed in 
MZ B cells. To exclude the possibility that the p100 degra-
dation defect was merely caused by an absence of certain 
BAFF-responsive B cell subsets, we used phospho-fl  ow cy-
tometry to assess p100 phosphorylation in unfractionated as 
well as sorted MZ versus FO B cell populations. Although 
rare, we were able to sort suffi   cient numbers of CD23  low   B 
cells from MALT1      /      mice, and these were confi  rmed not 
to be T1 B cells because of high expression of CD21 (Fig. S2). 
After a 15-min treatment with recombinant BAFF, WT 
B cells exhibited a shift in phospho-p100 (serines 866 and 
870) compared with unstimulated controls that was evident 
in total unfractionated B cells (B220  +  ), FO B cells (CD-
23  high  CD21  low  ), and MZ B cells (CD23  low  CD21  high  ;   Fig. 2 B  ). 
Phospho-p100 returned to baseline levels after 60 min of 
treatment. In contrast, BAFF-induced p100 phosphorylation 
was not observed in total MALT1      /      B cells or in the frac-
tionated MZ or FO B cell subsets (  Fig. 2 B  ). Thus, MALT1 
is involved in BAFF-induced p100 phosphorylation and deg-
radation in both MZ and FO B cell compartments. 
    Figure 2.     BAFF-induced p100 phosphorylation and degradation are diminished in MALT1      /      B cells.   (A) Highly purifi  ed B220  +   cells from spleens 
of WT and MALT1     /     mice were stimulated with 2 μg/ml BAFF for the indicated times. Cytoplasmic lysates were Western blotted to detect p100, p52, 
RelB, and tubulin, and nuclear lysates were probed with anti-p52, anti-RelB, and lamin A as a loading control. Results shown are representative of four 
independent analyses. (B) BAFF-stimulated B cells were immunostained with anti-CD21–PE and anti-CD23–FITC, fi  xed, permeabilized, and stained for 
anti–phospho-p100. Results shown are representative of fi  ve independent analyses (  n   = 5 mice/genotype). (C) MALT1 was ablated in the BJAB cell line 
using nucleofected siRNA as described. Cells were collected 48 h after nucleofection, stimulated with BAFF, and lysed. Cytoplasmic lysates were probed 
with MALT1, and nuclear lysates were probed with RelB and lamin as described. Blots are representative of two independent analyses. (D) MALT1 was 
knocked down in BJAB cells, and intracellular phospho-fl  ow detecting phosphorylation of p100 in response to BAFF or MegaAPRIL was conducted. Results 
are representative of three independent analyses. BJAB cells were also nucleofected with NF-    B2 siRNA and assessed for intracellular levels of phospho-
p100. Protein levels in NF-    B2 knockdown BJAB cells compared with scrambled siRNA controls are also displayed. Results are representative of two inde-
pendent analyses. Numbers to the left of gels represent kilodaltons.     JEM VOL. 206, November 23, 2009 
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ever, after 72 h of culture, WT B cells exhibited an     7.5-fold 
increase in survival over nonstimulated controls, whereas 
MALT1      /      B cells showed only a 3-fold increase in survival 
(Fig. S4 A, left). Unstimulated B cells isolated from WT or 
MALT1      /      mice showed no diff  erence in survival (Fig. S4 A, 
right). Because BAFF does not expand FO B cells during 
protracted (72 h) in vitro culture (  Batten et al., 2000  ), we 
postulated that the diff  erences we observed at this time point 
were caused by preferential eff  ects of BAFF on specifi  c sub-
sets of B cells. Therefore, we evaluated the viability of iso-
lated FO versus MZ B cells from WT and MALT1      /      mice 
after 72 h of culture. Interestingly, we found that MALT1 
was dispensable for BAFF-induced survival of BAFF-stimulated 
FO B cells (  Fig. 3 A  , i) but is necessary for optimal BAFF-
stimulated MZ B cell survival (  Fig. 3 A  , ii).   In addition, BAFF 
treatment up-regulated mRNAs for Bcl-2, Bcl-xL, cyclin 
D1, and cyclin D2 in FACS-sorted FO and MZ B cells from 
WT mice. Oligos used in real-time PCR analysis are displayed 
BJAB cells treated with MegaAPRIL, a TACI/BCMA dual 
agonist, further indicating that the p100 phosphorylation in 
BJAB cells is exclusively mediated by BAFF-R rather than 
TACI and BCMA (  Fig. 2 D  ). Collectively, these data confi  rm 
that MALT1 is necessary for an NF-    B2 signaling pathway 
triggered by stimulation of BAFF-R. 
  BAFF-induced survival and antiapoptotic gene induction 
are reduced in MALT1      /      CD21  high  CD23  low   MZ B cells 
  BAFF promotes B cell survival by activating the transcription 
of various antiapoptotic genes. To assess the role of MALT1 
in BAFF-mediated survival, we treated purifi  ed, resting B220  +   
B cells with recombinant BAFF and assessed their viability by 
annexin V/propidium iodide (PI) staining over a time course. 
In preliminary experiments, no diff  erences were observed be-
tween MALT1  +/+   and MALT1      /      B cells, depicted by the 
fold increase in viable cells (Fig. S4 A, left) or the percentage 
of viable cells (Fig. S4 A, right) after 48 h of culture. How-
    Figure 3.     BAFF-induced survival and antiapoptotic gene induction are reduced in MALT1      /      B cells.   (A) Fold increase in survival and absolute 
viable cell numbers of FO B cells (i) or MZ B cells (ii) isolated from the indicated genotypes and stimulated with BAFF for 72 h. Results shown are mean 
viabilities ± SD of four independent analyses with at least fi  ve mice per genotype. Black bars are BAFF treated and white bars are media controls. 
(B) cDNAs from unstimulated or BAFF-stimulated (2 μg/ml for 72 h) FO and MZ B cells from MALT1  +/+   and  MALT1    /     mice were amplifi  ed using PCR to 
detect the indicated prosurvival factors. Results shown are mean fold increases in mRNA induction over unstimulated controls and are representative 
of three independent analyses.     2676 The role of MALT1 in BAFF-mediated effects   | Tusche et al. 
defi  ciency of either MALT1 or Bcl10 in the BAFF-Tg back-
ground led to signifi  cant decreases in all isotypes compared 
with BAFF-Tg controls (  Fig. 5 A  ). We observed the same 
phenomenon when MALT1 was defi  cient only in B cells in 
BAFF-Tg mice (  Fig. S6 A  ). Thus, the enhanced Ig produc-
tion observed in BAFF-Tg mice requires not only Bcl10 but 
also B cell–intrinsic MALT1, and excess BAFF cannot restore 
the defective Ig production observed in Bcl10      /      and 
MALT1      /      mice. 
  B1 B cells are greatly reduced in Bcl10      /      and MALT1      /      
mice (  Ruland et al., 2001, 2003  ), and our fl  ow cytometric 
analysis revealed that Bcl10      /      mice harbor an unusual popu-
lation of CD5  low  IgM  low   cells in the peritoneal cavity (  Fig. 5 
B  , top). We asked whether excess BAFF could rescue B1 B 
cells in the peritoneal cavity of Bcl10      /      and MALT1      /      
mice. Bcl10 or MALT1 defi   ciency in a BAFF-Tg back-
ground resulted in frequencies of B1 B cells that were similar 
to Bcl10      /      and MALT1      /      mice (  Fig. 5 B  , top; and   Fig. 5 
C  , left) The same was true when absolute numbers of B1 B 
cells were tabulated (  Table S1  ). Therefore, excess BAFF can-
not restore B1 B cells in Bcl10      /      and MALT1      /      mice. 
in   Table S2  . However, 48 h of BAFF treatment failed to 
induce these prosurvival factors in MALT1      /      MZ B cells, 
whereas the fold induction of Bcl-2 and Bcl-xL and cyclin 
D1 in MALT1      /      FO B cells was similar to MALT1  +/+   con-
trols (  Fig. 3 B  ). Basal levels of the factors analyzed were found 
to be similar between WT and knockout in all cell types ana-
lyzed (unpublished data). Thus, MALT1 is important for 
BAFF-induced survival and for the up-regulation of anti-
apoptotic genes specifi  cally in MZ B cells. 
  MALT1 interacts with TRAF3 and this interaction 
is negatively regulated by BAFF 
  TRAF3 has been shown to negatively regulate survival signals 
emanating from the BAFF-R, particularly in MZ B cells 
(  Gardam et al., 2008  ). Because we have shown that MALT1 
seems to preferentially regulate BAFF-mediated survival in the 
MZ compartment, we addressed whether TRAF3 levels were 
dysregulated in MALT      /      MZ B cells. Accordingly, cell ly-
sates from sorted FO and MZ B cells were probed by Western 
blotting. TRAF3 was present at low levels in FO B cells, and 
no diff  erences were observed between WT and MALT1      /      
FO B cells (  Fig. 4 A  , left).   However, MALT1      /      MZ B cells 
exhibited a baseline higher level of TRAF3 protein compared 
with MALT1  +/+   MZ B cells (  Fig. 4 A  , right). We next sought 
to determine whether MALT1 and TRAF3 form a complex 
that can be regulated by BAFF by stimulating BJAB cells with 
BAFF for 0, 2, 4, and 24 h, immunoprecipitated MALT1, and 
probed for TRAF3. In unstimulated cells, TRAF3 was found 
to form a complex with MALT1 that dissociated at 2 and 4 h, 
reforming at 24 h (  Fig. 4 B  ). We also observed an association 
between MALT1 and TRAF3 in primary B220  +   B cells that 
was relieved by treatment with BAFF (  Fig. 4 C  ), although 
with slower kinetics. Therefore, TRAF3 levels are increased 
in the absence of MALT1, and TRAF3 forms a complex with 
MALT1 that is negatively regulated by BAFF stimulation. 
  BAFF-induced increases in serum Ig, MZ B cells, 
and B1 B cells are impaired in MALT1      /      mice 
  To examine the role of MALT1 in BAFF-dependent eff  ects 
in vivo, we crossed MALT1      /      mice with BAFF-Tg mice. 
BAFF-Tg mice exhibit increases in some serum Ig isotypes. 
Therefore, we fi  rst conducted sandwich ELISAs on serum 
samples obtained from WT, BAFF-Tg, MALT1      /     , and 
MALT1      /      × BAFF-Tg animals to assess if this was a MALT1-
dependent phenomenon. Bcl10      /      and Bcl10      /      × BAFF-
Tg mice, which were expected to be refractory to nonlimiting 
levels of BAFF because of the critical role of Bcl10 down-
stream of the BCR (  Ruland et al., 2001  ;   Xue et al., 2003  ), 
were analyzed in parallel as negative controls. The serum of 
BAFF-Tg mice contained signifi  cant increases in IgA, IgM, 
IgG  2c  , and IgG  3   compared with nontransgenic WT controls 
(  Fig. 5 A  ).   More moderate increases in IgG  1   and IgG  2b   were 
also observed in these animals. Sera from MALT1      /      and 
Bcl10      /      mice exhibited a marked reduction in all Ig isotypes 
analyzed, consistent with published reports (  Ruland et al., 2001, 
2003  ;   Ruefl  i-Brasse et al., 2003  ;   Xue et al., 2003  ). Strikingly, 
    Figure 4.     TRAF3 protein is increased in MALT1      /      MZ B cells, and 
MALT1 interacts with TRAF3 in a manner that is negatively regu-
lated by BAFF.   (A) MZ and FO B cells were isolated from the indicated 
genotypes. Lysates were obtained and Western blotted for TRAF3 and 
actin as a loading control. Blots are representative of four independent 
analyses. (B) BJAB cells or (C) primary B220  +   B cells were starved for 2 h 
and stimulated with 2 μg/ml BAFF for the indicated times, and MALT1 was 
immunoprecipitated. Immunoprecipitates were probed with TRAF3 and 
MALT1 as a control. Whole cell extracts were probed with TRAF3, MALT1, 
and tubulin as a loading control. Numbers to the left of gels represent 
kilodaltons. IP, immunoprecipitation; WCE, whole cell extracts.     JEM VOL. 206, November 23, 2009 
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Bcl10      /      mice (  Ruland et al., 2001, 2003  ;   Ruefl  i-Brasse 
et al., 2003  ;   Xue et al., 2003  ). Furthermore, these data dem-
onstrate that the increases in MZ and B1 B cells caused by 
BAFF overexpression is dependent on MALT1 for their full 
manifestation. These results further corroborate our fi  ndings 
(  Figs. 2–4  ) that BAFF-R–mediated activation of alternative 
NF-    B is impaired in the absence of MALT1. 
  Impaired T-dependent (Td) and T-independent (Ti) humoral 
responses in the absence of MALT1 
  BAFF-R is required for optimal Td B cell responses, and Ti 
responses are augmented in BAFF-Tg mice (  Schneider, 2005  ). 
To assess whether MALT1 is important for the eff  ects of BAFF 
on Td responses, we immunized WT, MALT1      /     , and 
Bcl10      /      mice and their BAFF-Tg counterparts with the Td 
antigen NP–chicken     -globulin (CGG). NP-CGG immuniza-
tion induced a modest increase in the frequency of GC B cells 
(Fas  +  GL7  +  ) in WT mice (  Fig. 6, A and B  ).   Numbers of GC B 
cells were already elevated in unimmunized BAFF-Tg mice, 
with a further increase observed when these mice were immu-
nized (  Fig. 6, A and B  ). However, even in the presence of ex-
cess BAFF antigen–specifi  c B cell responses could not be 
mounted in the absence of MALT1, as judged by the frequency 
  Although a lack of MALT1 did not alter total B220  +  CD23  +   
B cell numbers in the spleen (Table S1), fl  ow cytometric anal-
ysis revealed altered homeostasis of MZ B cells. Because 
BAFF-Tg mice have a greatly expanded MZ B cell compart-
ment (  Fig. 5 B  , bottom; and   Fig. 5 C  , right;   Mackay et al., 
1999  ) as well as a sixfold increase in the absolute numbers of 
these cells (Table S1), we asked if overexpression of BAFF 
could rescue MZ B cells in MALT1      /      mice. Bcl10      /      × 
BAFF-Tg and MALT1      /      × BAFF-Tg animals showed both 
a lower percentage (  Fig. 5 B  , bottom; and   Fig. 5 C  , right) and 
decreased absolute numbers (Table S1) of splenic MZ B cells 
compared with BAFF-Tg mice. A mild nonstatistically signifi  -
cant increase in MZ B cells was observed in the MALT1      /      × 
BAFF-Tg mice compared with the MALT1      /      mice, but 
this was signifi   cantly less than what was observed in the 
MALT1  +/+   × BAFF-Tg mice. In addition, a marked absence 
of CD23  low  CD21  high  CD1d  high   B cells was apparent in both of 
the Bcl10      /      backgrounds with or without the BAFF trans-
gene (  Fig. 5 B  , bottom; and   Fig. 5 C  , right). Curiously, 
Bcl10      /      but not MALT1      /      mice exhibited an unusual pop-
ulation of CD23  low  CD21  low   cells (with or without the BAFF 
transgene;   Fig. 5 B  , bottom). Collectively, our data confi  rm a 
signifi  cant reduction of MZ and B1 B cells in MALT1      /      and 
    Figure 5.     MALT1 is required for BAFF-induced increases in basal serum Ig, MZ B cells, and B1 B cells.   (A) Serum samples from 8–10-wk-old 
mice of the indicated genotypes were analyzed by ELISA to detect the indicated Ig isotypes. Data shown are levels for individual mice (  n   = 3–9 mice/
genotype) and the horizontal bars are means. Results shown are one trial representative of four independent analyses. (B) Peritoneal cells from 8–10-wk-old 
mice of the indicated genotypes were pregated on B220, and the B1 B cell population was isolated as IgM  high CD5 high   (top). Splenocytes from 8–10-wk-old 
mice of the indicated genotypes were pregated on B220 and CD23 (bottom). The B220  high CD23 low   population was isolated and further fractionated to 
examine MZ B cells (CD21  high CD1d high  ). FACS plots shown are representative of six independent analyses. (C) The cells in B were quantifi  ed, and the results 
are expressed as mean percentages of B220  +   cells ± SD of four independent analyses (  n   = 6–14 mice/genotype). B-Tg, BAFF-Tg.     2678 The role of MALT1 in BAFF-mediated effects   | Tusche et al. 
In addition, BAFF-Tg spleens (from either the WT or mixed 
bone marrow chimeric backgrounds) that were stained with 
MAdCAM-1 to delineate the MZ sinus showed that the MZ 
was increased in size (  Fig. 7 A  , bottom). This MZ expansion 
was not observed in MALT1      /      × BAFF-Tg or Bcl10      /      × 
BAFF-Tg mice. Similar results were obtained for MALT1      /      
and Bcl10      /      mixed bone marrow chimeras, suggesting a B 
cell–intrinsic requirement for MALT1/Bcl10 for an expanded 
MZ (Fig. S6 B). 
  BAFF-Tg mice exhibit mild glomerulonephritis charac-
terized by Ig deposition in the kidney mesangium (  McCarthy 
et al., 2006  ). Using immunofl  uorescence, we detected depos-
its of IgM, IgG, and IgA in sections of kidneys from BAFF-Tg 
animals (  Fig. 7 B  ). These Ig deposits were not present in 
kidney sections obtained from MALT1      /      × BAFF-Tg or 
Bcl10      /      × BAFF-Tg mice (  Fig. 7 B  ), or in mice where 
MALT1/Bcl10 are exclusively lacking in B cells (Fig. S6 B). 
Thus, the major histological abnormalities associated with 
BAFF overexpression require B cell–intrinsic MALT1 expres-
sion for their manifestation. 
and numbers of total GC B cells (  Fig. 6, A and B  ) and by mea-
suring titers of low affi   nity (NP-30) and high affi   nity (NP-3) 
antibodies directed against NP-CGG (  Fig. 6 C  , left, top and 
bottom) or Ti antigen NP-Ficoll (  Fig. 6 D  ). The same was true 
if MALT1 was absent exclusively in B cells in BAFF-Tg mice 
(  Fig. S7  ). As expected, Bcl10      /      × BAFF-Tg mice also failed 
to mount a Td response in the presence or absence of the BAFF 
transgene (  Fig. 6, A and B  ). Therefore, we observed that B 
cell–intrinsic expression of MALT1 is necessary to mount both 
Td and Ti response even in the presence of excess BAFF. 
  BAFF-induced GC formation in the spleen and Ig deposition 
in the kidney require MALT1 
  BAFF-Tg mice exhibit a high frequency of PNA  +   GC net-
works in the absence of immunization (  Mackay et al., 1999  ), 
a phenomenon we also observed (  Fig. 7 A  , top).   In contrast, 
no PNA  +   cells were identifi  ed in sections of spleens from 
MALT1      /      × BAFF-Tg animals, indicating that the forma-
tion of BAFF-induced spontaneous GCs requires MALT1. 
Similar results were obtained for Bcl10      /      × BAFF-Tg mice. 
    Figure 6.     Td and Ti humoral responses are dysfunctional in the absence of MALT1.   (A and B) Mice of the indicated genotypes (  n   = 4 mice/
genotype) were left unimmunized (unim) or immunized (imm) with the Td antigen NP-CGG. GC B cells in the spleens of these mice were detected by 
immunostaining plus fl  ow cytometry (percentages are shown). The quantifi  cation of the results of two such independent analyses are shown in B. Mice 
immunized with (C) the Td antigen NP-CGG or (D) the Ti antigen NP-Ficoll were analyzed by sandwich ELISA for the presence of low affi  nity (NP-30) and 
high affi  nity (NP-3) anti-NP antibodies. One out of two representative experiments is shown (  n   = 4 mice/genotype for each experiment). For B–D, white 
bars represent unimmunized controls and black bars represent immunized mice.     JEM VOL. 206, November 23, 2009 
Article
2679
induced signaling events can also be arrested in the BJAB cell 
line by siRNA-mediated knockdown of MALT1, thus cor-
roborating our fi  ndings in the knockout mice. Because this 
cell line is derived from a human Burkitt’s lymphoma, MALT1 
may also play a role in BAFF activation of NF-    B2 in the 
human system. Based on the block in B cell maturation in the 
MALT1      /      mice and the fact that signals downstream of 
the BAFF-R are necessary for B cell survival, we place this 
signaling node downstream of the BAFF-R rather than TACI 
or BCMA, which are also know to bind BAFF (  Marsters et al., 
2000  ;   Thompson et al., 2000  ;   Wu et al., 2000  ;   Thompson et 
al., 2001  ;   Yan et al., 2001  ;   Ruefl  i-Brasse et al., 2003  ;   Ruland 
et al., 2003  ). The observation that siRNA-mediated MALT1 
knockdown in the BJAB cell line, which only expresses 
BAFF-R, arrests BAFF-induced signal transduction corrobo-
rates this notion (  Thompson et al., 2001  ). 
  Although MALT1 is essential for BAFF-driven NF-    B2 
activation in all B cell subsets, the requirement for MALT1 for 
BAFF-mediated B cell survival is only manifested in MZ B 
cells. Specifi  cally, in response to BAFF stimulation, MALT1      /      
FO B cells exhibited normal BAFF-stimulated survival in vitro 
accompanied by up-regulation of Bcl-2, Bcl-xL, and cyclin D1, 
yet all of these readouts are MALT1 dependent in MZ B cells. 
The only exception to this pattern was in the case of cyclin D2 
that seems to require MALT1 in both MZ and FO B cell sub-
sets, suggesting that there are other cell-cycle entry mediators 
that compensate for cyclin D2 in MALT      /      FO B cells. Our 
fi  ndings potentially explain why MALT1      /      as well as RelB      /      
and   aly/aly   mice do not phenocopy BAFF      /      mice but share 
some similarities (  Shinkura et al., 1999  ;   Weih et al., 2001  ). The 
reason for the incomplete phenocopy is likely because the 
MALT1– NF-    B2 axis induces an essential BAFF-mediated 
survival program in MZ B cells that is redundant in FO B cells. 
Indeed, mice with B cell–specifi  c ablation of TRAF2/3 and 
constitutive activation of the alternative NF-    B pathway have 
a preferentially expanded MZ B cell compartment, suggesting 
that MZ B cells are particularly sensitive to TRAF3 degrada-
tion. Indeed, TRAF3 levels have been shown to be low in FO 
B cells (  Gardam et al., 2008  ), suggesting that this adaptor (and 
by extension NF-    B2 signaling) may be more relevant for the 
“fi  ne tuning” of BAFF-R signals in the MZ compartment. The 
phosphoinositide 3-kinase (PI3-kinase) pathway is a possible 
candidate for the alternative BAFF-dependent survival pathway 
that sustains MALT1      /      FO B cells (  Patke et al., 2006  ). In sup-
port of this concept, we found that pharmacologic inhibition of 
p110     abrogated the BAFF-dependent survival of WT and 
MALT1      /      FO B cells with relatively little eff  ect on MZ B 
cells (  Fig. S5  ). Another possibility is that Bcl10 could compen-
sate for the absence of MALT1 in FO B cells. Indeed, we have 
observed defects in BAFF-induced signaling and survival in 
Bcl10      /      B220  +   B cells (unpublished data). The fact that 
Bcl10      /      mice have a defect in FO B cell development as well 
as MZ development lends credence to this hypothesis. 
  BAFF-Tg mice exhibit pathological features such as hyper-
globulinemia, spontaneous GC formation, and Ig deposition 
in the kidneys (  Mackay et al., 1999  ), and we show that this 
  DISCUSSION 
  Although modest defects in signaling downstream of the 
BCR have been reported for MALT1      /      mice (  Ferch et al., 
2007  ), we fi  nd that these defects do not impinge on B cell 
activation in terms of IgM-induced proliferation, NF-    B ac-
tivation, or B7 up-regulation. Nevertheless, MZ B cells as well 
as serum Ig titers are signifi  cantly decreased in our MALT1      /      
mice, implying that B cell survival signals other than those 
mediated by the BCR require MALT1. Because BAFF over-
expression has been reported to drive the expansion of MZ B 
cells, as well as to support GC responses and induce class switch 
recombination, we investigated whether MALT1 plays a role 
in BAFF signaling (  Kalled, 2006  ). 
  We demonstrate for the fi  rst time that MALT1 is inte-
grated in a novel signaling pathway induced by BAFF, and 
MALT1 is necessary for the full manifestation of BAFF-
dependent in vivo eff  ects. Specifi  cally, we show that BAFF-
induced phosphorylation of NF-    B2 (p100) in FO and MZ B 
cells is dependent on MALT1. Furthermore, we demonstrate 
that BAFF-induced degradation of p100 and RelB nuclear 
translocation is diminished in the absence of MALT1. BAFF-
    Figure 7.     BAFF-induced GC formation in the spleen and Ig deposi-
tion in the kidney require MALT1.   (A) Spleen sections from mice of the 
indicated genotypes were immunostained to detect B220 plus the GC 
marker PNA (top) or B220 plus the MZ sinus marker MAdCAM-1 (bottom). 
Arrows indicate PNA  +   GC B cells. (B) Kidney sections from the mice in A 
were stained with FITC-conjugated antibodies specifi  c for the indicated Ig 
isotypes and visualized using fl  uorescence microscopy. Images shown are 
representative of four independent analyses of at least eight mice/genotype.     2680 The role of MALT1 in BAFF-mediated effects   | Tusche et al. 
rescue MZ and FO B cell development in a BAFF-R      /      back-
ground. The implication is that in situations of enforced activa-
tion of BAFF- or BCR-initiated pathways, BAFF and BCR 
signaling activities can compensate for one another. 
  A recent report revealed that c-IAP1/2 acts as an E3 ubiq-
uitin ligase and polyubiquitinates NIK in a Lys-48–dependent 
manner. c-IAP1/2 is brought in proximity to TRAF3 via 
TRAF2, and TRAF3 in turn links this complex with NIK. 
Stabilization of NIK is achieved by recruitment of the complex 
to the membrane upon receptor aggregation, resulting in a 
TRAF2-dependent activation of c-IAP1/2 that induces the 
K48-mediated ubiquitination of TRAF3 and its degradation. 
TRAF3 degradation allows for NIK to be relieved from this 
complex so that it may initiate alternative NF-    B signaling 
(  Vallabhapurapu et al., 2008  ). Interestingly, we have found that 
MALT1 and TRAF3 coassociate in BJAB cells and primary 
mouse B cells (  Fig. 4, B and C  ). We propose that MALT1 
serves as a scaff  old for c-IAP1/2, TRAF2, and TRAF3, with 
TRAF3 in turn binding to NIK. However, this scaff  old may 
not be necessary for the constitutive activity of c-IAP1/2 on 
NIK itself. In contrast, upon receptor activation, the MALT1 
scaff  old may play an important role in allowing c-IAP1/2 to 
polyubiquitinate TRAF3 on K48, leading to its degradation. In 
agreement with this possibility, we have observed that TRAF3 
is elevated in MZ B cells obtained from MALT1      /      mice (  Fig. 
4 A  ). Furthermore, upon BAFF stimulation, we found that the 
TRAF3–MALT1 complex dissociates, keeping with the notion 
that TRAF3 is rapidly degraded after BAFF-R signaling. There 
are two possibilities for how MALT1 may function after recep-
tor activation: either MALT1 encourages TRAF2 to activate c-
IAP1/2 by bringing them into closer proximity while recruited 
to the activated BAFF-R, or alternatively MALT1, perhaps 
through a protein conformational change that occurs upon cell 
signaling, may bring activated c-IAP1/2 into closer proximity 
with TRAF3 itself. Either scenario would promote TRAF3 
degradation and the activation of NF-    B2. Future experiments 
will be designed to distinguish between these possibilities. 
  Both Bcl10 and MALT1 are frequently involved in trans-
locations associated with extranodal MZ B cell lymphomas of 
mucosa-associated lymphoid tissues (MALT lymphomas; 
  Akagi et al., 1999  ;   Dierlamm et al., 1999  ;   Willis et al., 1999  ; 
  Zhang et al., 1999  ). However, mice transgenic for the API2–
MALT1 translocation do not develop lymphoma after 50 wk, 
implying that the presence of the fusion protein alone is not 
suffi   cient to drive neoplastic progression (  Baens et al., 2006  ). 
BAFF levels are elevated in the serum of patients with a variety 
of B cell malignancies (  Ng et al., 2005  ), and autocrine BAFF 
production is crucial for the survival of some B cell lympho-
mas (  Fu et al., 2006  ). One possibility is that MALT lymphom-
agenesis is driven by MALT1 translocations because they 
dysregulate BAFF activity. It would be intriguing to investi-
gate whether MALT lymphoma patients have elevated BAFF 
levels in their serum. 
  In summary, we have shown both in vitro and in vivo that 
MALT1 is crucial for many of the biological eff  ects mediated by 
BAFF. Our results suggest that MALT1 is a critical intermediate 
phenotype does not occur in the absence of MALT1. In ad-
dition, the expansion of the B1 B cell compartment in the 
peritoneum has also been reported in BAFF-Tg animals, al-
beit to varying degrees in diff  erent studies (  Mackay et al., 
1999  ;   Khare et al., 2000  ;   Gavin et al., 2005  ). In our hands, 
we see reproducible increases in the B1 B cell population in 
the presence of the BAFF transgene that are ablated in the 
context of either MALT1 or Bcl10 defi  ciency. In addition, 
the increase in MZ B cells typically found in BAFF-Tg mice 
critically requires MALT1. GC B cell maintenance and Ig 
class switching depend on BAFF-R signaling (  Kalled, 2006  ). 
Interestingly, some Ig titers are decreased in MALT1      /      
mice, as well as the GC response to antigen (  Figs. 5 A   and   6 A  ). 
These were not corrected by excess BAFF, further support-
ing a role for MALT1 in BAFF-R signaling. Because GC re-
sponses are seeded by FO B cells, we hypothesize that as FO 
B cells become activated and rapidly proliferate within the GC 
niche, other BAFF-mediated survival programs that normally 
support FO B cell survival, such as PI3-kinase activation, are no 
longer suffi   cient within this highly cytotoxic milieu. Therefore, 
like MZ B cells, GC B cells may require MALT1-dependent 
alternative NF-    B activation in response to BAFF stimulation. 
  Because both Bcl10 and MALT1 are required for TCR 
signaling, it was important to determine whether Bcl10 and 
MALT1 functions were required in B cells themselves for 
these BAFF-induced eff  ects. In addition, BAFF has been 
known to have a co-stimulatory eff  ect on T cells, and the de-
fect in Td antigen response we observe in MALT1      /      mice 
could be caused by this eff  ect (  Mackay and Leung, 2006  ). In-
deed, using mixed bone marrow chimeric BAFF-Tg × J  h        /      
mice that contain WT T cells and knockout B cells, we found 
that BAFF-induced increases in GC formation and kidney Ig 
deposition as well as the elevation of global Ig and antigen-
specifi  c Ig all require B cell–intrinsic expression of MALT1 
(and Bcl10; Figs. S6 and S7). Therefore, MALT1 must be 
expressed in B cells to mediate BAFF-driven eff  ects in vivo. 
  Given that BCR-mediated proliferation and canonical 
NF-    B activation are intact in MALT1      /      mice (  Fig. 1  ), the 
absences of MZ B and B1 cells in these mice are likely not 
caused by a lesion in BCR signaling, and our data strongly sug-
gest that these defects are caused by impaired NF-    B2 activa-
tion downstream of BAFF-R. However, the possibility exists 
that an unknown factor is nonfunctional in MALT1      /      mice 
and generates a phenotype that cannot be rescued by BAFF 
overexpression. The reported block in MALT1      /      mice of the 
activation of c-Rel–containing NF-    B heterodimers in re-
sponse to BCR signaling could represent such a possibility 
(  Ferch et al., 2007  ). In contrast, Bcl10      /      mice exhibit non-
functional NF-    B signaling, B cell proliferation, and a 
CD23  low   compartment that is dominated by T1 (CD21  low  ) 
B cells, suggesting an underlying BCR lesion (  Figs. 1   and   5 B  ). 
Therefore, it is impossible to tell whether the lack of MZ and 
B1 B cells in Bcl10      /      mice is caused by perturbations down-
stream of the BCR or signaling defects in the BAFF-induced 
noncanonical NF-    B pathway.   Sasaki et al.   (  2006  ) report that 
constitutively active canonical NF-    B signaling in B cells can JEM VOL. 206, November 23, 2009 
Article
2681
reactions were fractionated on TBE gels (Bio-Rad Laboratories) and visual-
ized using an Odyssey infrared imager. 
  B cell survival assays.     MZ (CD21  high  CD23  low  ), FO (CD21  low  CD23  high  ), 
and T2 (CD21  high  HSA  high  ) B cells were isolated from total B220  +   B cells us-
ing a cell sorter (FACSAria; BD). FACS-sorted B cells were cultured for 72 
h with or without 2 μg/ml of recombinant BAFF. Unfractionated B220  +   B 
cells were cultured with BAFF for the times indicated in the fi  gures. 5 μg/ml 
anti-IgM was used in survival studies for the indicated times. Viability was 
assessed using annexin V/PI staining and acquired on a fl  ow  cytometer 
(FACSCalibur; BD). Survival was expressed as the fold increase in viable 
cells over untreated controls, or as the percentage of viable cells. IC87114 
(a gift from K. Okkenhaug, Babraham Institute, Cambridge, England, UK) 
was resuspended in DMSO and used at a fi  nal concentration of 15 μM. 
  Serum Ig ELISA.     Ig isotypes were determined using standard ELISA of 
serially diluted mouse serum samples. Primary antibodies recognizing mouse 
Igs and horseradish peroxidase (HRP)–linked secondary antibodies recog-
nizing specifi  c isotypes were obtained from SouthernBiotech. Ig standards 
were from eBioscience. 
  Flow cytometry.     Peritoneal lavage was conducted by injecting 8 ml PBS 
into the peritoneum of a euthanized mouse and massaging gently for 2 min. 
Recovered peritoneal cells were resuspended in FACS buff  er and incubated 
with anti-CD11b–FITC, anti-B220–allophycocyanin (APC; both from eBio-
science), anti-CD5–PE, and anti-IgM–Cyc (both from BD). Immunostained 
cells were washed in FACS buff  er and resuspended in 2% paraformaldehyde. 
Total splenocytes were collected from spleens as described, resuspended in 
FACS buff  er, and incubated with anti-CD21–FITC, anti-IgM–CyC, anti-
B220–PE (all from BD), anti-CD1d–PE, and anti-CD23–biotin followed by 
incubation with streptavidin-APC (all from eBioscience). For BAFF-R stain-
ing, whole splenocytes were incubated with anti-CD4–PE, anti-B220–FITC 
(both from BD), and BAFF-R–biotin (the gift of S. Kalled, Biogen Idec, 
Cambridge, MA), followed by incubation with streptavidin-APC. For B7 up-
regulation experiments, splenocytes were incubated with a cocktail consisting 
of B220-PerCP, CD21-FITC, CD23-PE, and B7.1/B7.2 (CD80/86)-APC 
(all from BD). Immunostained splenocytes were washed in FACS buff  er and 
resuspended in 2% paraformaldehyde. Samples were processed using a FACS-
Calibur and analyzed using FlowJo software (Tree Star, Inc.). 
  Immunoprecipitation.     Cells were treated with stimulus and washed once 
with cold PBS. Cells were resuspended in 1 ml of modifi  ed RIPA buff  er (50 
mM Tris-Cl [pH 7.4], 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 
1 mM EDTA, 1 mM PMSF, and protease and phosphatase inhibitor cocktail 
tablets), incubated at 4°C with constant rotation, and centrifuged to remove 
debris. Lysates were precleared by adding 30 μl Protein G Sepharose 4 Fast 
Flow (GE Healthcare) and rotating at 4°C for 30 min. Precleared lysates 
were incubated with a 1:100 dilution of anti-MALT1 (Santa Cruz Biotech-
nology, Inc.) and overnight at 4°C with constant rotation. Immunocom-
plexes were precipitated with 30 μl Protein G Sepharose 4 Fast Flow with 
rotation at 4°C for 30 min, eluted by boiling in Laemmli buff  er, fractionated 
on SDS-PAGE gels, and immunoblotted according to standard protocols. 
  Intracellular phospho-fl  ow cytometry.     5 × 10  5   B220  +   B cells or BJAB 
cells were stimulated at 37°C with 2 μg/ml BAFF or MegaAPRIL (Enzo 
Life Sciences, Inc.) for the times indicated in the fi  gures. Cells were fi  xed 
with paraformaldehyde and permeablized in 1 ml Phosphofl  ow Perm Buff  er 
III (90% methanol based; BD). After washing, cells were stained with an an-
tibody cocktail consisting of 1:100 dilutions of anti-CD21–PE, anti-CD23–
FITC (both from BD), and anti–phospho-p100 (Ser 866/870), and incubated 
on ice for 30 min. After washing in FACS buff  er (PBS containing 3%FCS 
and 0.09% sodium azide), cells were stained with a 1:1,000 dilution of anti–
rabbit Alexa Fluor 647 (Molecular Probes) for 1 h on ice. Cells were washed, 
resuspended in FACS buff  er, and acquired using a fl  ow cytometer (FACS-
Canto; BD). Samples were analyzed using FlowJo software. 
in a novel signaling pathway emanating from BAFF-R, which 
drives the survival and expansion of MZ B cells. MALT1 may 
thus represent an attractive target for therapeutic intervention 
in the treatment of lymphoma or autoimmunity. 
  MATERIALS AND METHODS 
  Mice.     The generation of Bcl10      /     , MALT1      /     , and BAFF-Tg mice was 
described previously (  Mackay et al., 1999  ;   Ruland et al., 2001, 2003  ). 
BAFF-Tg mice were provided by J. Browning and A. Ranger (Biogen Idec, 
Cambridge, MA). Bcl10      /      × BAFF-Tg and MALT1      /      × BAFF-Tg mice 
were maintained with the transgene expressed heterozygously to generate lit-
termate controls. BAFF-Tg  +/      and BAFF-Tg  +/+   mice have equivalent phe-
notypes (  McCarthy et al., 2006  ). J  h        /      mice were obtained from S. Fillatreau 
(Deutsches Rheuma-Forschungszentrum, Berlin, Germany;   Gu et al., 1993  ). 
Mice were analyzed at 8–10 wk of age. All animal experiments were con-
ducted using protocols approved by the Animal Use Committee of the Uni-
versity of Toronto. 
  Proliferation.     Spleens from WT, Bcl10      /     , and MALT1      /      mice were 
homogenized and erythrocytes were removed using Red Blood Cell Lysing 
Buff  er (Sigma-Aldrich). B220  +   B cells were isolated by negative depletion 
using biotinylated anti-CD11b, anti–Thy 1.2, and anti-Ter119 antibodies 
plus streptavidin-conjugated magnetic beads (BD). Purity of B220  +   cells was 
confi  rmed to be >95% using fl  ow cytometry. 2 × 10  5   cells per well were 
cultured in 96-well plates in RPMI 1640 medium supplemented with 10% 
FCS, 5 mM   l  -glutamine, 55 μM 2-mercaptoethanol, and antibiotics, and 
stimulated with the indicated doses of anti-IgM (Jackson ImmunoResearch 
Laboratories) or anti-CD40 (clone 3/23; BD) for the times indicated in   Fig. 
1   and Fig. S1. 1     Ci [  3  H]thymidine (PerkinElmer) was added for the last 
8 h of culture. Proliferation was measured using a microplate scintillation 
counter (Top Count NXT; Packard). 
  Immunoblotting.     B cells were serum-starved for 4 h and stimulated in 
OptiMEM medium with or without 2 μg/ml recombinant BAFF (Pepro-
Tech) at 37°C for the times indicated in the fi  gures. For anti-IgM or CD40L 
treatment, starved B cells were stimulated with 5 μg/ml anti–mouse IgM or 
250 ng/ml soluble CD40L (PeproTech) for the indicated times, respectively. 
For the preparation of cytosolic extracts, cells were resuspended in lysis buff  er 
(50 mM Tris-Cl [pH 7.4], 250 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM 
PMSF, 1 mM NaF, 1 mM Na  4  VO  3  , and complete protease inhibitor cocktail 
[Roche]). For the preparation of nuclear lysates, cells were resuspended in 
buff  er A (10 mM Hepes [pH 7.4], 10 mM KCl, 0.1 mM EDTA supple-
mented with 1 mM PMSF, 1 mM dithiothreitol, and phosphatase and prote-
ase inhibitor cocktails [Roche]), for 15 min on ice with occasional agitation. 
NP-40 was added to a fi  nal concentration of 0.65% and incubated for a fur-
ther 15 min on ice. Samples were centrifuged at 10,000 rpm for 1 min at 4°C 
to pellet nuclei. Nuclear pellets were resuspended in buff  er C (20 mM Hepes 
[pH 7.9], 0.4 M NaCl, 1 mM EDTA, and 1 mM EGTA supplemented as 
described) for 30 min on ice with occasional agitation. Lysates were cleared 
by centrifugation, at 14,000 rpm for 10 min at 4°C, normalized for protein 
content, and Western blotted according to standard protocols. Blots were 
probed with the indicated antibodies and visualized using enhanced chemi-
luminescence according to the manufacturer’s protocol (GE Healthcare). 
Blots were stripped and reprobed with antitubulin or antiactin antibodies 
(Sigma-Aldrich) as a loading control. Antibodies against I    B    , NF-    B2 
(p100/p52), RelB, and phospho-p100 (Ser 866/870) were obtained from 
Cell Signaling Technology. Antibodies against MALT1, PKC    , lamin A, 
TRAF2, and TRAF3 were obtained from Santa Cruz Biotechnology, Inc. 
  EMSA.     B cells were serum starved and stimulated for 8 h in 5 μg/ml anti-
IgM, and nuclear extracts were prepared as described. 2.5-μg nuclear lysate 
samples were analyzed for DNA binding using an EMSA kit (Odyssey IR; 
LI-COR Biosciences). For supershift assays, 1 μl anti-p65 (Santa Cruz Bio-
technology, Inc.) was added to a DNA binding reaction before addition of 
labeled oligo and was incubated at room temperature for 20 min. Binding 2682 The role of MALT1 in BAFF-mediated effects   | Tusche et al. 
Fig. S6 A shows basal serum Ig levels of mixed bone marrow chimeric mice from 
the indicated genotypes. WT+J  h        /     →WT denotes WT bone marrow mixed 
with J  h        /      bone marrow, introduced into a WT lethally irradiated recipient. Fig. 
S6 B shows immunohistochemical and immunofl  uorescence analysis of spleen 
and kidney sections, respectively, of mixed bone marrow chimeric mice from 
the indicated genotype. Fig. S7 A shows GC B cell frequencies in the spleens of 
the indicated genotypes of mixed bone marrow chimeric mice that had been left 
unimmunized (white bars) and immunized with Td antigen NP-CGG (black 
bars). Fig. S7 B shows NP-CGG (Td) antibody titers in mixed bone marrow 
chimeric mice. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20091802/DC1. 
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